What is the recommended dose and administration schedule of midazolam (Versed) for adult palliative sedation, including initial bolus, continuous infusion, and adjustments for elderly patients, those with liver dysfunction, or when IV access is unavailable?

Midazolam Dosing for Palliative Care

For adult palliative sedation, start with midazolam 2.5-5 mg subcutaneously every 2-4 hours as needed for anxiety or agitation, transitioning to a continuous subcutaneous infusion of 10 mg over 24 hours if needed more than twice daily. 1

Initial Dosing Strategy

For Anxiety or Agitation (Unable to Swallow)

• Bolus dose: 2.5-5 mg subcutaneously every 2-4 hours as required 1
• Continuous infusion: If breakthrough doses needed more than twice daily, initiate subcutaneous infusion via syringe driver starting at 10 mg over 24 hours 1

Dose Adjustments for Special Populations

Renal Impairment: Reduce continuous infusion dose to 5 mg over 24 hours if eGFR <30 mL/min 1

Elderly or Debilitated Patients:

• Reduce initial bolus doses by approximately 50% 2
• For IV sedation in patients >60 years: start with no more than 1.5 mg over 2 minutes (compared to 2.5 mg in younger adults) 2
• Elderly patients require at least 50% less midazolam than healthy young adults 2

Hepatic Dysfunction: While specific dose reductions aren't explicitly stated in guidelines, one study found deranged liver function was associated with better symptom control, suggesting these patients may be more sensitive to midazolam 3. Consider starting at lower doses and titrating carefully.

Continuous Infusion Dosing

Starting dose: 10 mg/24 hours subcutaneously 1

Titration: The dose range varies considerably based on individual response:

• Mean doses in clinical practice: 10-48 mg/24 hours 4
• Typical effective range: 1-20 mg/hour (24-480 mg/24 hours) 5
• One study reported mean starting dose of 31 mg/24 hours, increasing to mean maximum of 48 mg/24 hours 4
• Another study showed effective control at 0.4-0.8 mg/hour initially, rising to mean maximum of 2.9 mg/hour (approximately 70 mg/24 hours) 6

Important caveat: Asian populations may require lower doses than Western guidelines suggest. A Hong Kong study found mean doses of only 10 mg/day (range 5-45 mg) were effective 3, substantially lower than Western recommendations.

Alternative Routes When IV/SC Access Unavailable

Oral/Sublingual (if patient can swallow):

• Lorazepam 0.5-1 mg orally four times daily as required (maximum 4 mg/24 hours) 1
• Reduce to 0.25-0.5 mg in elderly/debilitated patients (maximum 2 mg/24 hours) 1
• Oral tablets can be used sublingually (off-label) 1

Intramuscular:

• 0.2 mg/kg (maximum 6 mg per dose) for seizures; may repeat every 10-15 minutes 7
• This route is less commonly used in palliative care but remains an option

Combination Therapy

With Delirium: Consider adding or switching to:

• Levomepromazine 12.5-25 mg subcutaneously as starting dose, then hourly as required (use 6.25-12.5 mg in elderly) 1
• Maintain with subcutaneous infusion of 50-200 mg over 24 hours 1
• Midazolam can be combined with levomepromazine if anxiety also present 1

With Opioids: When midazolam is co-administered with opioids, reduce midazolam dose by approximately 30% due to synergistic effects 2

Critical Monitoring Points

• Respiratory depression is the primary risk, especially when combined with opioids 8, 9
• Peak effect occurs at 3-5 minutes after IV administration 2
• Duration of effect: 15-80 minutes for single doses 8, 9
• Paradoxical agitation may occur, particularly in younger children and elderly patients 7, 5, 2
• Have flumazenil available as reversal agent if needed 5

Common Pitfalls to Avoid

1. Insufficient waiting time: After each dose increment, wait at least 2-3 minutes to assess full effect before redosing 2

2. Overlooking reversible causes: Always address treatable causes of agitation first (pain, urinary retention, constipation, hypoxia) before initiating sedation 1, 10

3. Inadequate dose titration: The wide dose range (5-480 mg/24 hours) emphasizes the critical need for careful individual titration 5, 6

4. Ignoring drug accumulation: With continuous infusion beyond 24 hours, reassess frequently and reduce dose as needed to prevent accumulation, especially in neonates and patients with renal/hepatic impairment 2

5. Rapid administration: Never give as rapid IV bolus; administer over at least 2 minutes to minimize respiratory depression and hypotension 2